Volume : 10, Issue : 04, April – 2023
Title:
30.FORMULATION AND EVALUATION OF TRANSDERMAL PATCH CONTAINING CLOTRIMAZOLE AND TURMERIC OIL
Authors :
Alka. T*, Prakash. C, Ankush. S, Manish. V, T.Smitha
Abstract :
Background :-An antifungal medication with a biological half-life of two hours, clotrimazole has gastrointestinal adverse effects when used orally at doses of 500 mg twice daily. The goal of this study is to create a transdermal drug delivery system for Clotrimazole and turmeric oil that will deliver the medication to a specific site to treat a fungal infection and lessen any potential sensitization or irritation issues.
Method:- A turmeric oil is first extracted from the turmeric rhizomes, and then these transdermal patches were made using the solvent casting method using the placebo method. Different combinations of polymer were used with the solvents MDC and methanol in a 1:1 ratio, and polyethylene glycol 500 and propylene glycol were used as permeation enhancers and plasticizers. The manufactured patches were assessed for weight fluctuation, thickness, weight variation, moisture absorption, moisture uptake, folding endurance, flatness, drug content, and in-vivo permeation study during the analysis of the compatibility study
RESULT:-In vitro drug release studies for all formulations revealed that the first dose of drug was released in 2 to 2.5 hours, and the complete dose was released (95%) within 24 hours. The formulation were uniform in their physical characteristics combinations of three polymers HPMC, EC, and EUDRAGIT RS-100, implying excellent quality and uniformity in patch characteristics as compared to other combinations of polymers.
Conclusion:- Transdermal patches made of Clotrimazole and turmeric oil were successfully created, and their evaluation indicated good quality and uniformity in patch characteristics. These patches may have therapeutic effects and provide benefits such as lowering the frequency of doses required for treatment, increasing patient compliance, and increasing bioavailability.
Keywords:-Clotrimazole, Turmeric oil, Eudragit RS 100,HPMC, EC, Transdermal drug delivery system
Cite This Article:
Please cite this article in press Alka. T et al, Formulation and evaluation of transdermal patch containing clotrimazole and Turmeric oil., Indo Am. J. P. Sci, 2023; 10 (04).
Number of Downloads : 10
References:
1. Patch, T. FORMULATION AND EVALUATION OF CLOTRIMAZOLE LOADED. 2020, 9 (10), 790–803. https://doi.org/10.20959/wjpr202010-18480.
2. Crowley P.D, Gallagher H.C. Clotrimazole as a pharmaceutical: past, present and future by journal of Applied Microbiology, ISSN 1364-5072.
3. Jalwal P, Jangra A, Dhaiya L, Sangwan Y, Saroha R. A review on transdermal patches. Pharm res. J., 2010; 3: 139-149.
4. Bhowmik D, Chiranjib, Chandira M, Jayakar B, Sampath K. Recent advances in transdermal drug delivery system. IJPTR, 2010; 2(1): 68-87.
5. Rani S, Saroha K, Syan N, Mathur P. Transdermal patches a successful tool in Transdermal Drug Delivery system : An overview. Der Pharmacia Sinica, 2011; 2(5): 17-29.
6. Hafeez A, Jain U, Singh J, Maurya A. Recent advance in transdermal drug delivery system: An overview. Journal of Scientific and Innovative Research. 2013; 2(3): 695-709.
7. Kaur A, Kumar S.L. Controlled drug delivery approaches for eheumatoid arthritis. Journal of Applied Pharmaceutical Sciences, 2012; 2(8): 21-32.
8. Divya A, Rao M.K, Gaanprakash K, Sowjanya A, Vidyasagar N, Gobinath M. A review on current cenario of transdermal drug delivery system. IJRPS, 2012; 3(4): 494-502.
9. Dash S, Murthy N.P, Nath L. kinetic modeling on drug release from controlled drug delivery system. Acta Poloniae Pharmaceutical Drug Research, 2010; 67(3): 217-223.
10. Ranade, V. V. Drug Delivery Systems. 6. Transdermal Drug Delivery. J. Clin. Pharmacol. 1991, 31 (5), 401–418. https://doi.org/10.1002/j.1552-4604.1991.tb01895.x.
11. Kadhim, M. J.; Kaizal, A. F.; Hameed, I. H. Medicinal Plants Used for Treatment of Rheumatoid Arthritis: A Review. Int. J. Pharm. Clin. Res. 2016, 8 (12), 1685–1694.
12. Nawaz, A.; Khan, G. M.; Shah, S. U.; Shah, K. U.; Asim-ur-Rehman; Hussain, A. Preparation and Evaluation of Clotrimazole Matrix Type Patch: Effect of Olive Oil on Drug Penetration across Rabbit Skin. Proc. Pakistan Acad. Sci. 2011, 48 (2), 95–100.
13. Crowley, P. D.; Gallagher, H. C. Clotrimazole as a Pharmaceutical: Past, Present and Future. J. Appl. Microbiol. 2014, 117 (3), 611–617. https://doi.org/10.1111/jam.12554.
14. Vishwakarma, A. K.; Maurya, O. P.; Nimisha; Srivastava, D. Formulation and Evaluation of Transdermal Patch Containing Turmeric Oil. Int. J. Pharm. Pharm. Sci. 2012, 4 (SUPPL. 5), 358–361.
15. Abdul Rasool, B. K.; Mohammed, A. A.; Salem, Y. Y. The Optimization of a Dimenhydrinate Transdermal Patch Formulation Based on the Quantitative Analysis of in Vitro Release Data by DDSolver through Skin Penetration Studies. Sci. Pharm. 2021, 89 (3). https://doi.org/10.3390/scipharm89030033.
16. Deemed, B. V. Bhatia et Al.,. 2014, 5 (2), 600–606.
17. Prajapati, S. T.; Patel, C. G.; Patel, C. N. Formulation and Evaluation of Transdermal Patch of Repaglinide. ISRN Pharm. 2011, 2011, 1–9. https://doi.org/10.5402/2011/651909.
18. Singh, A.; Bali, A. Formulation and Characterization of Transdermal Patches for Controlled Delivery of Duloxetine Hydrochloride. J. Anal. Sci. Technol. 2016, 7 (1). https://doi.org/10.1186/s40543-016-0105-6.
19. Tiwary, A. K.; Sapra, B.; Jain, S. Innovations in Transdermal Drug Delivery: Formulations and Techniques. Recent Pat. Drug Deliv. Formul. 2007, 1 (1), 23–36. https://doi.org/10.2174/187221107779814087.
20. Kharia, A.; Singhai, A. K.; Gilhotra, R. Formualtion and Evalaution of Transdermal Patch for the Treatment of Inflammation. J. Pharm. Sci. Res. 2020, 12 (6), 780–788.
21. Mamatha, J.; Gadili, S.; Pallavi, K. Formulation and Evaluation of Zidovudine Transdermal Patch Using Permeation Enhancers. J. Young Pharm. 2020, 12 (2s), s45–s50. https://doi.org/10.5530/jyp.2020.12s.45.
22. Wagh, M. P.; Dalvi, H.; Bagal, M. Formulation and Evaluation of Transdermal Drug Delivery System for Simvastatin. Indian Drugs 2009, 46 (3), 221–225. https://doi.org/10.4103/jphi.JPHI.
23. Al-Eraky, M. M.; Mohamed, N.; Kamel, F.; Al-Qahtani, A.; Madini, M. A.; Hussin, A.; Kamel, N. M. F. Of Advanced Research Teaching Professionalism By Vignettes in Psychiatry for Nursing Students. Int. J. Adv. Res. 2016, 4 (6), 625–634. https://doi.org/10.21474/IJAR01.
24. Amnuaikit, C.; Ikeuchi, I.; Ogawara, K.-I.; Higaki, K.; Kimura, T. Skin Permeation of Propranolol from Polymeric Film Containing Terpene Enhancers for Transdermal Use. Int. J. Pharm. 2005, 289 (1–2), 167–178. https://doi.org/10.1016/j.ijpharm.2004.11.007.
25. Rana, A. C.; Saini, S.; Singh, G. Research Article Formulation and Evaluation of Fexofenadine Hydrochloride. 2012, 2 (5), 20–23.
26. El-Gendy, N. A.; Sabry, N. A.; El-Attar, M.; Omar, E.; Mahmoud, M. Transdermal Delivery of Salbutamol Sulphate: Formulation and Evaluation. Pharm. Dev. Technol. 2009, 14 (2), 216–225. https://doi.org/10.1080/10837450802572383.
27. Tadhi, N.; Chopra, H.; Sharma, G. K. Formulation and Evaluation of Transdermal Patch of Methimazole. Res. J. Pharm. Technol. 2021, 14 (9), 4667–4672. https://doi.org/10.52711/0974-360X.2021.00811.
28. Iman, I.; Nadia, A.; Ebtsam, M. Formulation and Stability Study of Chlorpheniramine Maleate Transdermal Patch. Asian J. Pharm. 2010, 4 (1), 17–23. https://doi.org/10.4103/0973-8398.63978.
29. Mahajan, N. M.; Zode, G. H.; Mahapatra, D. K.; Thakre, S.; Dumore, N.; Gangane, P. S. Formulation Development and Evaluation of Transdermal Patch of Piroxicam for Treating Dysmenorrhoea. J. Appl. Pharm. Sci. 2018, 8 (11), 35–41. https://doi.org/10.7324/JAPS.2018.81105.
30. Arora, P.; Mukherjee, B. Design, Development, Physicochemical, and in Vitro and in Vivo Evaluation of Transdermal Patches Containing Diclofenac Diethylammonium Salt. J. Pharm. Sci. 2002, 91 (9), 2076–2089. https://doi.org/10.1002/jps.10200.
31. Tanwar, H.; Sachdeva, R.; Jambheshwar, G. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH HTML Full Text TRANSDERMAL DRUG DELIVERY SYSTEM: A REVIEW. CiteScore 2018.